Sonoma Pharmaceuticals (SNOA) Total Liabilities (2011 - 2025)

Sonoma Pharmaceuticals' Total Liabilities history runs 15 years deep, the most recent figure standing at $10.2 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 15.83% year-over-year to $10.2 million; the TTM figure through Dec 2025 stood at $10.2 million (up 15.83% YoY), while the FY2025 annual figure was $9.3 million, up 7.89% from the prior year.
• Total Liabilities was $10.2 million for Q4 2025 at Sonoma Pharmaceuticals, up from $10.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $10.5 million in Q2 2025 to a low of $7.9 million in Q4 2023.
• Historically, Total Liabilities has averaged $8.9 million across 5 years, with a median of $8.7 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Total Liabilities soared 38.26% in 2021, then dropped 18.66% in 2023.
• A 5-year view of Total Liabilities shows it stood at $8.2 million in 2021, then rose by 2.34% to $8.4 million in 2022, then retreated by 5.29% to $7.9 million in 2023, then climbed by 11.0% to $8.8 million in 2024, then grew by 15.83% to $10.2 million in 2025.
• The last three Total Liabilities figures came in at $10.2 million (Q4 2025), $10.1 million (Q3 2025), and $10.5 million (Q2 2025), per Business Quant data.